Fuzhi Song
Chief Executive Officer bei GENEX PHARMACEUTICAL, INC.
Profil
Fuzhi Song is currently the Chairman, President & Chief Executive Officer at Genex Pharmaceutical, Inc. since 2004 and also the Chairman at Tianjin Zhongjin Biology Development Co. Ltd.
since 2003.
Previously, he was the Chief Executive Officer at Tianjin Zhongjin Pharmageutical Co. Ltd.
from 1998 to 1999 and Chairman at Tianjin Jinshi Group.
Aktive Positionen von Fuzhi Song
| Unternehmen | Position | Beginn |
|---|---|---|
| GENEX PHARMACEUTICAL, INC. | Chief Executive Officer | - |
Tianjin Zhongjin Biology Development Co. Ltd.
 Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million. | Chairman | 24.02.2010 |
Ehemalige bekannte Positionen von Fuzhi Song
| Unternehmen | Position | Ende |
|---|---|---|
| Tianjin Zhongjin Pharmageutical Co. Ltd. | President | 01.11.1999 |
| Tianjin Jinshi Group | Chairman | 01.01.1999 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENEX PHARMACEUTICAL, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Tianjin Zhongjin Biology Development Co. Ltd.
Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million. | Health Technology |
| Tianjin Zhongjin Pharmageutical Co. Ltd. | |
| Tianjin Jinshi Group |
